New methods for analysis of oxysterols and related compounds by LC–MS

Journal of Steroid Biochemistry and Molecular Biology

Volumn 162, Issue , 2016, Pages 4-26

  Griffiths, William J ^a   Abdel Khalik, Jonas ^a   Crick, Peter J ^a   Yutuc, Eylan ^a   Wang, Yuqin ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Cholesterol; Derivatisation; Epoxycholesterol; Hydroxycholesterol; Liquid chromatography; Mass spectrometry; Sterol

Indexed keywords

CHOLESTEROL; CHOLESTEROL SULFATE; DIMETHYLGLYCINE; ESTER DERIVATIVE; GLUCURONIDE; HYDRAZONE DERIVATIVE; NICOTINIC ACID DERIVATIVE; OXIME DERIVATIVE; OXYSTEROL; PICOLINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; STEROL;

CEREBROSPINAL FLUID; CEREBROTENDINOUS XANTHOMATOSIS; CHOLESTEROL METABOLISM; DERIVATIZATION; ENZYME ACTIVITY; EX VIVO STUDY; HUMAN; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; PRECURSOR; REVIEW; STANDARD; STEROL ANALYSIS; VALIDATION PROCESS; ANIMAL; BLOOD; METABOLISM; PROCEDURES; VALIDATION STUDY;

ANIMALS; CHOLESTEROL; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY; OXYSTEROLS; VALIDATION STUDIES AS TOPIC;

EID: 84950157937     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.11.017     Document Type: Review

References (111)

1. [1] Dietschy, J.M., Turley, S.D., Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45 (2004), 1375–1397.
2. [2] Schroepfer, G.J. Jr., Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80 (2000), 361–554.
3. [3] Javitt, N.B., Oxysterols: novel biologic roles for the 21st century. Steroids 73 (2008), 149–157.
4. [4] Bergström, S., Wintersteiner, O., Autoxidation of sterols in colloidal aqueous solution. The nature of the products formed from cholesterol. J. Biol. Chem. 141 (1941), 597–610.
5. [5] Iuliano, L., Pathways of cholesterol oxidation via non-enzymatic mechanisms. Chem. Phys. Lipids 164 (2011), 457–468.
6. [6] Murphy, R.C., Johnson, K.M., Cholesterol, reactive oxygen species, and the formation of biologically active mediators. J. Biol. Chem. 283 (2008), 15521–15525.
7. [7] Larsson, H., Böttiger, Y., Iuliano, L., Diczfalusy, U., In vivo interconversion of 7beta-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress. Free Radic. Biol. Med. 43 (2007), 695–701.
8. [8] Shinkyo, R., Xu, L., Tallman, K.A., Cheng, Q., Porter, N.A., Guengerich, F.P., Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate. J. Biol. Chem. 286 (2011), 33021–33028.
9. [9] Russell, D.W., The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72 (2003), 137–174.
10. [10] Clayton, P.T., Verrips, A., Sistermans, E., Mann, A., Mieli-Vergani, G., Wevers, R., Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J. Inherit. Metab Dis. 25 (2002), 501–513.
11. [11] Clayton, P.T., Disorders of bile acid synthesis. J. Inherit. Metab. Dis. 34 (2011), 593–604.
12. [12] Dai, D., Mills, P.B., Footitt, E., Gissen, P., McClean, P., Stahlschmidt, J., Coupry, I., Lavie, J., Mochel, F., Goizet, C., Mizuochi, T., Kimura, A., Nittono, H., Schwarz, K., Crick, P.J., Wang, Y., Griffiths, W.J., Clayton, P.T., Liver disease in infancy caused by oxysterol 7 alpha-hydroxylase deficiency: successful treatment with chenodeoxycholic acid. J. Inherit. Metab. Dis. 37 (2014), 851–861.
13. [13] Setchell, K.D., Heubi, J.E., Defects in bile acid biosynthesis–diagnosis and treatment. J Pediatr. Gastroenterol. Nutr. 43:Suppl. (1) (2006), S17–S22.
14. [14] Lund, E.G., Guileyardo, J.M., Russell, D.W., cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 7238–7243.
15. [15] Björkhem, I., Rediscovery of cerebrosterol. Lipids 42 (2007), 5–14.
16. [16] Björkhem, I., Lovgren-Sandblom, A., Leoni, V., Meaney, S., Brodin, L., Salveson, L., Winge, K., Pålhagen, S., Svenningsson Oxysterols, P., Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. Neurosci. Lett. 555 (2013), 102–105.
17. [17] Papassotiropoulos, A., Lütjohann, D., Bagli, M., Locatelli, S., Jessen, F., Rao, M.L., Maier, W., Björkhem, I., von, B.K., Heun, R., Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. Neuroreport 11 (2000), 1959–1962.
18. [18] Bauman, D.R., Bitmansour, A.D., McDonald, J.G., Thompson, B.M., Liang, G., Russell, D.W., 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 16764–16769.
19. [19] Diczfalusy, U., Olofsson, K.E., Carlsson, A.M., Gong, M., Golenbock, D.T., Rooyackers, O., Flaring, U., Björkbacka, H., Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res. 50 (2009), 2258–2264.
20. [20] Blanc, M., Hsieh, W.Y., Robertson, K.A., Kropp, K.A., Forster, T., Shui, G., Lacaze, P., Watterson, S., Griffiths, S.J., Spann, N.J., Meljon, A., Talbot, S., Krishnan, K., Covey, D.F., Wenk, M.R., Craigon, M., Ruzsics, Z., Haas, J., Angulo, A., Griffiths, W.J., Glass, C.K., Wang, Y., Ghazal, P., The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 38 (2013), 106–118.
21. [21] Hannedouche, S., Zhang, J., Yi, T., Shen, W., Nguyen, D., Pereira, J.P., Guerini, D., Baumgarten, B.U., Roggo, S., Wen, B., Knochenmuss, R., Noel, S., Gessier, F., Kelly, L.M., Vanek, M., Laurent, S., Preuss, I., Miault, C., Christen, I., Karuna, R., Li, W., Koo, D.I., Suply, T., Schmedt, C., Peters, E.C., Falchetto, R., Katopodis, A., Spanka, C., Roy, M.O., Detheux, M., Chen, Y.A., Schultz, P.G., Cho, C.Y., Seuwen, K., Cyster, J.G., Sailer, A.W., Oxysterols direct immune cell migration via EBI2. Nature 475 (2011), 524–527.
22. [22] Liu, C., Yang, X.V., Wu, J., Kuei, C., Mani, N.S., Zhang, L., Yu, J., Sutton, S.W., Qin, N., Banie, H., Karlsson, L., Sun, S., Lovenberg, T.W., Oxysterols direct B-cell migration through EBI2. Nature 475 (2011), 519–523.
23. [23] Reboldi, A., Dang, E.V., McDonald, J.G., Liang, G., Russell, D.W., Cyster, J.G., Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345 (2014), 679–684.
24. [24] Theofilopoulos, S., Wang, Y., Kitambi, S.S., Sacchetti, P., Sousa, K.M., Bodin, K., Kirk, J., Salto, C., Gustafsson, M., Toledo, E.M., Karu, K., Gustafsson, J.A., Steffensen, K.R., Ernfors, P., Sjövall, J., Griffiths, W.J., Arenas, E., Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis. Nat. Chem. Biol. 9 (2012), 126–133.
25. [25] Theofilopoulos, S., Griffiths, W.J., Crick, P.J., Yang, S., Meljon, A., Ogundare, M., Kitambi, S.S., Lockhart, A., Tuschl, K., Clayton, P.T., Morris, A.A., Martinez, A., Reddy, M.A., Martinuzzi, A., Bassi, M.T., Honda, A., Mizuochi, T., Kimura, A., Nittono, H., De, M.G., Carbone, R., Criscuolo, C., Yau, J.L., Seckl, J.R., Schule, R., Schols, L., Sailer, A.W., Kuhle, J., Fraidakis, M.J., Gustafsson, J.A., Steffensen, K.R., Björkhem, I., Ernfors, P., Sjövall, J., Arenas, E., Wang, Y., Cholestenoic acids regulate motor neuron survival via liver X receptors. J. Clin. Invest. 124 (2014), 4829–4842.
26. [26] Janowski, B.A., Grogan, M.J., Jones, S.A., Wisely, G.B., Kliewer, S.A., Corey, E.J., Mangelsdorf, D.J., Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 266–271.
27. [27] Lehmann, J.M., Kliewer, S.A., Moore, L.B., Smith-Oliver, T.A., Oliver, B.B., Su, J.L., Sundseth, S.S., Winegar, D.A., Blanchard, D.E., Spencer, T.A., Willson, T.M., Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272 (1997), 3137–3140.
28. [28] Ruan, B., Wilson, W.K., Schroepfer, G.J. Jr., An improved synthesis of (20R,22R)-cholest-5-ene-3beta,20,22-triol, an intermediate in steroid hormone formation and an activator of nuclear orphan receptor LXR alpha. Steroids 64 (1999), 385–395.
29. [29] Meljon, A., Theofilopoulos, S., Shackleton, C.H., Watson, G.L., Javitt, N.B., Knolker, H.J., Saini, R., Arenas, E., Wang, Y., Griffiths, W.J., Analysis of bioactive oxysterols in newborn mouse brain by LC/MS. J. Lipid Res. 53 (2012), 2469–2483.
30. [30] Meljon, A., Wang, Y., Griffiths, W.J., Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse. Biochem. Biophys. Res. Commun. 446 (2014), 768–774.
31. [31] Fakheri, R.J., Javitt, N.B., 27-Hydroxycholesterol, does it exist? On the nomenclature and stereochemistry of 26-hydroxylated sterols. Steroids 77 (2012), 575–577.
32. [32] Crick, P.J., William, B.T., Abdel-Khalik, J., Matthews, I., Clayton, P.T., Morris, A.A., Bigger, B.W., Zerbinati, C., Tritapepe, L., Iuliano, L., Wang, Y., Griffiths, W.J., Quantitative charge-tags for sterol and oxysterol analysis. Clin. Chem. 61 (2015), 400–411.
33. [33] Crick, P.J., Beckers, L., Baes, M., Van Veldhoven, P.P., Wang, Y., Griffiths, W.J., The oxysterol and cholestenoic acid profile of mouse cerebrospinal fluid. Steroids 99 (2015), 172–177.
34. [34] Iuliano, L., Crick, P.J., Zerbinati, C., Tritapepe, L., Abdel-Khalik, J., Poirot, M., Wang, Y., Griffiths, W.J., Cholesterol metabolites exported from human brain. Steroids 99 (2015), 189–193.
35. [35] McDonald, J.G., Smith, D.D., Stiles, A.R., Russell, D.W., A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma. J. Lipid Res. 53 (2012), 1399–1409.
36. [36] Stiles, A.R., Kozlitina, J., Thompson, B.M., McDonald, J.G., King, K.S., Russell, D.W., Genetic, anatomic, and clinical determinants of human serum sterol and vitamin D levels. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E4006–E4014.
37. [37] Axelson, M., Mörk, B., Sjövall, J., Occurrence of 3 beta-hydroxy-5-cholestenoic acid, 3 beta,7 alpha-dihydroxy-5-cholestenoic acid, and 7 alpha-hydroxy-3-oxo-4-cholestenoic acid as normal constituents in human blood. J. Lipid Res. 29 (1988), 629–641.
38. [38] Lund, E., Andersson, O., Zhang, J., Babiker, A., Ahlborg, G., Diczfalusy, U., Einarsson, K., Sjövall, J., Björkhem, I., Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler. Thromb. Vasc. Biol. 16 (1996), 208–212.
39. [39] Meaney, S., Heverin, M., Panzenboeck, U., Ekström, L., Axelsson, M., Andersson, U., Diczfalusy, U., Pikuleva, I., Wahren, J., Sattler, W., Björkhem, I., Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid. J. Lipid Res. 48 (2007), 944–951.
40. [40] Dzeletovic, S., Breuer, O., Lund, E., Diczfalusy, U., Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225 (1995), 73–80.
41. [41] Lein, E.S., Hawrylycz, M.J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A.F., Boguski, M.S., Brockway, K.S., Byrnes, E.J., Chen, L., Chen, L., Chen, T.M., Chin, M.C., Chong, J., Crook, B.E., Czaplinska, A., Dang, C.N., Datta, S., Dee, N.R., Desaki, A.L., Desta, T., Diep, E., Dolbeare, T.A., Donelan, M.J., Dong, H.W., Dougherty, J.G., Duncan, B.J., Ebbert, A.J., Eichele, G., Estin, L.K., Faber, C., Facer, B.A., Fields, R., Fischer, S.R., Fliss, T.P., Frensley, C., Gates, S.N., Glattfelder, K.J., Halverson, K.R., Hart, M.R., Hohmann, J.G., Howell, M.P., Jeung, D.P., Johnson, R.A., Karr, P.T., Kawal, R., Kidney, J.M., Knapik, R.H., Kuan, C.L., Lake, J.H., Laramee, A.R., Larsen, K.D., Lau, C., Lemon, T.A., Liang, A.J., Liu, Y., Luong, L.T., Michaels, J., Morgan, J.J., Morgan, R.J., Mortrud, M.T., Mosqueda, N.F., Ng, L.L., Ng, R., Orta, G.J., Overly, C.C., Pak, T.H., Parry, S.E., Pathak, S.D., Pearson, O.C., Puchalski, R.B., Riley, Z.L., Rockett, H.R., Rowland, S.A., Royall, J.J., Ruiz, M.J., Sarno, N.R., Schaffnit, K., Shapovalova, N.V., Sivisay, T., Slaughterbeck, C.R., Smith, S.C., Smith, K.A., Smith, B.I., Sodt, A.J., Stewart, N.N., Stumpf, K.R., Sunkin, S.M., Sutram, M., Tam, A., Teemer, C.D., Thaller, C., Thompson, C.L., Varnam, L.R., Visel, A., Whitlock, R.M., Wohnoutka, P.E., Wolkey, C.K., Wong, V.Y., Wood, M., Yaylaoglu, M.B., Young, R.C., Youngstrom, B.L., Yuan, X.F., Zhang, B., Zwingman, T.A., Jones, A.R., Genome-wide atlas of gene expression in the adult mouse brain. Nature 445 (2007), 168–176.
42. [42] Björkhem, I., Andersson, U., Ellis, E., Alvelius, G., Ellegard, L., Diczfalusy, U., Sjövall, J., Einarsson, C., From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J. Biol. Chem. 276 (2001), 37004–37010.
43. [43] Meng, L.J., Griffiths, W.J., Nazer, H., Yang, Y., Sjovall, J., High levels of (24S)-24-hydroxycholesterol 3-sulfate, 24-glucuronide in the serum and urine of children with severe cholestatic liver disease. J. Lipid Res. 38 (1997), 926–934.
44. [44] Nelson, E.R., Wardell, S.E., Jasper, J.S., Park, S., Suchindran, S., Howe, M.K., Carver, N.J., Pillai, R.V., Sullivan, P.M., Sondhi, V., Umetani, M., Geradts, J., McDonnell, D.P., 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science 342 (2013), 1094–1098.
45. [45] Wu, Q., Ishikawa, T., Sirianni, R., Tang, H., McDonald, J.G., Yuhanna, I.S., Thompson, B., Girard, L., Mineo, C., Brekken, R.A., Umetani, M., Euhus, D.M., Xie, Y., Shaul, P.W., 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Rep. 5 (2013), 637–645.
46. [46] Umetani, M., Domoto, H., Gormley, A.K., Yuhanna, I.S., Cummins, C.L., Javitt, N.B., Korach, K.S., Shaul, P.W., Mangelsdorf, D.J., 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat. Med. 13 (2007), 1185–1192.
47. [47] Hult, M., Elleby, B., Shafqat, N., Svensson, S., Rane, A., Jörnvall, H., Abrahmsen, L., Oppermann, U., Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. Cell. Mol. Life Sci. 61 (2004), 992–999.
48. [48] Nelson, J.A., Steckbeck, S.R., Spencer, T.A., Biosynthesis of 24,25-epoxycholesterol from squalene 2,3;22,23-dioxide. J. Biol. Chem. 256 (1981), 1067–1068.
49. [49] Mazein, A., Watterson, S., Hsieh, W.Y., Griffiths, W.J., Ghazal, P., A comprehensive machine-readable view of the mammalian cholesterol biosynthesis pathway. Biochem. Pharmacol. 86 (2013), 56–66.
50. [50] Goyal, S., Xiao, Y., Porter, N.A., Xu, L., Guengerich, F.P., Oxidation of 7-dehydrocholesterol and desmosterol by human cytochrome P450 46A1. J. Lipid Res. 55 (2014), 1933–1943.
51. [51] Wang, Y., Sousa, K.M., Bodin, K., Theofilopoulos, S., Sacchetti, P., Hornshaw, M., Woffendin, G., Karu, K., Sjövall, J., Arenas, E., Griffiths, W.J., Targeted lipidomic analysis of oxysterols in the embryonic central nervous system. Mol. Biosyst. 5 (2009), 529–541.
52. [52] Wang, Y., Karu, K., Meljon, A., Turton, J., Yau, J.L., Seckl, J.R., Wang, Y., Griffiths, W.J., 24S,25-Epoxycholesterol in mouse and rat brain. Biochem. Biophys. Res. Commun. 449 (2014), 229–234.
53. [53] Lund, E.G., Xie, C., Kotti, T., Turley, S.D., Dietschy, J.M., Russell, D.W., Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278 (2003), 22980–22988.
54. [54] Heverin, M., Meaney, S., Brafman, A., Shafir, M., Olin, M., Shafaati, M., von, B.S., Larsson, L., Lövgren-Sandblom, A., Diczfalusy, U., Parini, P., Feinstein, E., Björkhem, I., Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 2191–2197.
55. [55] Helmschrodt, C., Becker, S., Thiery, J., Ceglarek, U., Preanalytical standardization for reactive oxygen species derived oxysterol analysis in human plasma by liquid chromatography–tandem mass spectrometry. Biochem. Biophys. Res. Commun. 446 (2014), 726–730.
56. [56] de, M.P., Paillasse, M.R., Segala, G., Voisin, M., Mhamdi, L., Dalenc, F., Lacroix-Triki, M., Filleron, T., Pont, F., Saati, T.A., Morisseau, C., Hammock, B.D., Silvente-Poirot, S., Poirot Dendrogenin, M., A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties. Nat. Commun., 4, 1840, 2013.
57. [57] Silvente-Poirot, S., Poirot, M., Cancer cholesterol and cancer, in the balance. Science 343 (2014), 1445–1446.
58. [58] Liu, W., Xu, L., Lamberson, C.R., Merkens, L.S., Steiner, R.D., Elias, E.R., Haas, D., Porter, N.A., Assays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patients. J. Lipid Res. 54 (2013), 244–253.
59. [59] Karu, K., Turton, J., Wang, Y., Griffiths, W.J., Nano-liquid chromatography–tandem mass spectrometry analysis of oxysterols in brain: monitoring of cholesterol autoxidation. Chem. Phys. Lipids 164 (2011), 411–424.
60. [60] Griffiths, W.J., Crick, P.J., Wang, Y., Methods for oxysterol analysis: past, present and future. Biochem. Pharmacol. 86 (2013), 3–14.
61. [61] Fourgeux, C., Martine, L., Pasquis, B., Maire, M.A., Acar, N., Creuzot-Garcher, C., Bron, A., Bretillon, L., Steady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat. Acta Ophthalmol. 90 (2012), e560–e567.
62. [62] Iuliano, L., Micheletta, F., Natoli, S., Ginanni, C.S., Iappelli, M., Elisei, W., Giovannelli, L., Violi, F., Diczfalusy, U., Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. Anal. Biochem. 312 (2003), 217–223.
63. [63] Leoni, V., Lutjohann, D., Masterman, T., Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis. J. Lipid Res. 46 (2005), 191–195.
64. [64] Matysik, S., Klunemann, H.H., Schmitz, G., Gas chromatography–tandem mass spectrometry method for the simultaneous determination of oxysterols, plant sterols, and cholesterol precursors. Clin. Chem. 58 (2012), 1557–1564.
65. [65] Schött, H.F., Lütjohann, D., Validation of an isotope dilution gas chromatography–mass spectrometry method for combined analysis of oxysterols and oxyphytosterols in serum samples. Steroids 99 (2015), 139–150.
66. [66] Heverin, M., Bogdanovic, N., Lütjohann, D., Bayer, T., Pikuleva, I., Bretillon, L., Diczfalusy, U., Winblad, B., Björkhem, I., Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 45 (2004), 186–193.
67. [67] Mast, N., Norcross, R., Andersson, U., Shou, M., Nakayama, K., Björkhem, I., Pikuleva, I.A., Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. Biochemistry 42 (2003), 14284–14292.
68. [68] Saeed, A., Floris, F., Andersson, U., Pikuleva, I., Lövgren-Sandblom, A., Bjerke, M., Paucar, M., Wallin, A., Svenningsson, P., Björkhem, I., 7alpha-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid reflects the integrity of the blood-brain barrier. J. Lipid Res. 55 (2014), 313–318.
69. [69] Quehenberger, O., Armando, A.M., Brown, A.H., Milne, S.B., Myers, D.S., Merrill, A.H., Bandyopadhyay, S., Jones, K.N., Kelly, S., Shaner, R.L., Sullards, C.M., Wang, E., Murphy, R.C., Barkley, R.M., Leiker, T.J., Raetz, C.R., Guan, Z., Laird, G.M., Six, D.A., Russell, D.W., McDonald, J.G., Subramaniam, S., Fahy, E., Dennis, E.A., Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51 (2010), 3299–3305.
70. [70] Bandaru, V.V., Haughey, N.J., Quantitative detection of free 24S-hydroxycholesterol, and 27-hydroxycholesterol from human serum. BMC. Neurosci., 15, 2014, 137.
71. [71] Burkard, I., Rentsch, K.M., von, E.A., Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography–mass spectrometry. J. Lipid Res. 45 (2004), 776–781.
72. [72] DeBarber, A.E., Lutjohann, D., Merkens, L., Steiner, R.D., Liquid chromatography–tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol. Anal. Biochem. 381 (2008), 151–153.
73. [73] Honda, A., Yamashita, K., Hara, T., Ikegami, T., Miyazaki, T., Shirai, M., Xu, G., Numazawa, M., Matsuzaki, Y., Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI–MS/MS. J. Lipid Res. 50 (2009), 350–357.
74. [74] Ikegami, T., Honda, A., Miyazaki, T., Kohjima, M., Nakamuta, M., Matsuzaki, Y., Increased serum oxysterol concentrations in patients with chronic hepatitis C virus infection. Biochem. Biophys. Res. Commun. 446 (2014), 736–740.
75. [75] Sidhu, R., Jiang, H., Farhat, N.Y., Carrillo-Carrasco, N., Woolery, M., Ottinger, E., Porter, F.D., Schaffer, J.E., Ory, D.S., Jiang, X., A validated LC–MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid. J. Lipid Res. 56 (2015), 1222–1233.
76. [76] Jiang, X., Ory, D.S., Han, X., Characterization of oxysterols by electrospray ionization tandem mass spectrometry after one-step derivatization with dimethylglycine. Rapid Commun. Mass Spectrom. 21 (2007), 141–152.
77. [77] Jiang, X., Sidhu, R., Porter, F.D., Yanjanin, N.M., Speak, A.O., te Vruchte, D.T., Platt, F.M., Fujiwara, H., Scherrer, D.E., Zhang, J., Dietzen, D.J., Schaffer, J.E., Ory, D.S., A sensitive and specific LC–MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J. Lipid Res. 52 (2011), 1435–1445.
78. [78] Liu, S., Sjövall, J., Griffiths, W.J., Neurosteroids in rat brain: extraction, isolation, and analysis by nanoscale liquid chromatography–electrospray mass spectrometry. Anal. Chem. 75 (2003), 5835–5846.
79. [79] DeBarber, A.E., Luo, J., Star-Weinstock, M., Purkayastha, S., Geraghty, M.T., Chiang, J.P., Merkens, L.S., Pappu, A.S., Steiner, R.D., A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns. J. Lipid Res. 55 (2014), 146–154.
80. [80] DeBarber, A.E., Luo, J., Giugliani, R., Souza, C.F., Chiang, J.P., Merkens, L.S., Pappu, A.S., Steiner, R.D., A useful multi-analyte blood test for cerebrotendinous xanthomatosis. Clin. Biochem. 47 (2014), 860–863.
81. [81] Crick, P.J., Aponte, J., Bentley, T.W., Matthews, I., Wang, Y., Griffiths, W.J., Evaluation of novel derivatisation reagents for the analysis of oxysterols. Biochem. Biophys. Res. Commun. 446 (2014), 756–761.
82. [82] Girard, A., Sandulesco G Sur une nouvelle série de réactifs du groupe carbonyle, leur utilisation à l'extraction des substances cétoniques et à la caractérisation microchimique des aldéhydes et cétones. Helv. Chim. Acta, 19, 1936, 1095.
83. [83] Roberg-Larsen, H., Strand, M.F., Grimsmo, A., Olsen, P.A., Dembinski, J.L., Rise, F., Lundanes, E., Greibrokk, T., Krauss, S., Wilson, S.R., High sensitivity measurements of active oxysterols with automated filtration/filter backflush-solid phase extraction–liquid chromatography–mass spectrometry. J. Chromatogr. A 1255 (2012), 291–297.
84. [84] Roberg-Larsen, H., Lund, K., Vehus, T., Solberg, N., Vesterdal, C., Misaghian, D., Olsen, P.A., Krauss, S., Wilson, S.R., Lundanes, E., Highly automated nano-LC/MS-based approach for thousand cell-scale quantification of side chain-hydroxylated oxysterols. J. Lipid Res. 55 (2014), 1531–1536.
85. [85] Roberg-Larsen, H., Vesterdal, C., Wilson, S.R., Lundanes, E., Underivatized oxysterols and nanoLC-ESI–MS: a mismatch. Steroids 99 (2015), 125–130.
86. [86] Lavrynenko, O., Nedielkov, R., Moller, H.M., Shevchenko, A., Girard derivatization for LC–MS/MS profiling of endogenous ecdysteroids in Drosophila. J Lipid Res. 54 (2013), 2265–2272.
87. [87] DeBarber, A.E., Connor, W.E., Pappu, A.S., Merkens, L.S., Steiner, R.D., ESI–MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis. Clin. Chim. Acta 411 (2010), 43–48.
88. [88] DeBarber, A.E., Sandlers, Y., Pappu, A.S., Merkens, L.S., Duell, P.B., Lear, S.R., Erickson, S.K., Steiner, RD, Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC–ESI–MS(n) analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879 (2011), 1384–1392.
89. [89] Soroosh, P., Wu, J., Xue, X., Song, J., Sutton, S.W., Sablad, M., Yu, J., Nelen, M.I., Liu, X., Castro, G., Luna, R., Crawford, S., Banie, H., Dandridge, R.A., Deng, X., Bittner, A., Kuei, C., Tootoonchi, M., Rozenkrants, N., Herman, K., Gao, J., Yang, X.V., Sachen, K., Ngo, K., Fung-Leung, W.P., Nguyen, S., de Leon-Tabaldo, A., Blevitt, J., Zhang, Y., Cummings, M.D., Rao, T., Mani, N.S., Liu, C., McKinnon, M., Milla, M.E., Fourie, A.M., Sun, S., Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation. Proc. Natl. Acad. Sci. U. S. A 111 (2014), 12163–12168.
90. [90] Griffiths, W.J., Liu, S., Alvelius, G., Sjövall, J., Derivatisation for the characterisation of neutral oxosteroids by electrospray and matrix-assisted laser desorption/ionisation tandem mass spectrometry: the Girard P derivative. Rapid Commun. Mass Spectrom. 17 (2003), 924–935.
91. [91] Griffiths, W.J., Wang, Y., Alvelius, G., Liu, S., Bodin, K., Sjövall, J., Analysis of oxysterols by electrospray tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 17 (2006), 341–362.
92. [92] Griffiths, W.J., Hornshaw, M., Woffendin, G., Baker, S.F., Lockhart, A., Heidelberger, S., Gustafsson, M., Sjövall, J., Wang, Y., Discovering oxysterols in plasma: a window on the metabolome. J. Proteome Res. 7 (2008), 3602–3612.
93. [93] Griffiths, W.J., Crick, P.J., Wang, Y., Ogundare, M., Tuschl, K., Morris, A.A., Bigger, B.W., Clayton, P.T., Wang, Y., Analytical strategies for characterization of oxysterol lipidomes: liver X receptor ligands in plasma. Free Radic. Biol. Med. 59 (2013), 69–84.
94. [94] Karu, K., Hornshaw, M., Woffendin, G., Bodin, K., Hamberg, M., Alvelius, G., Sjövall, J., Turton, J., Wang, Y., Griffiths, W.J., Liquid chromatography–mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. J. Lipid Res. 48 (2007), 976–987.
95. [95] Ogundare, M., Theofilopoulos, S., Lockhart, A., Hall, L.J., Arenas, E., Sjövall, J., Brenton, A.G., Wang, Y., Griffiths, W.J., Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain?. J. Biol. Chem. 285 (2010), 4666–4679.
96. [96] Wang, Y., Hornshaw, M., Alvelius, G., Bodin, K., Liu, S., Sjovall, J., Griffiths, W.J., Matrix-assisted laser desorption/ionization high-energy collision-induced dissociation of steroids: analysis of oxysterols in rat brain. Anal. Chem. 78 (2006), 164–173.
97. [97] Wheeler, O.H., The Girard reagents. J. Chem. Educ. 45 (1968), 435–437.
98. [98] Shackleton, C.H., Chuang, H., Kim, J., de, l.T., Segura, X., Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids 62 (1997), 523–529.
99. [99] MacLachlan, J., Wotherspoon, A.T., Ansell, R.O., Brooks, C.J., Cholesterol oxidase: sources, physical properties and analytical applications. J. Steroid Biochem. Mol. Biol. 72 (2000), 169–195.
100. [100] Abdel-Khalik, J., Crick, P.J., Carter, G.D., Makin, H.L., Wang, Y., Griffiths, W.J., Studies on the analysis of 25-hydroxyvitamin D(3) by isotope-dilution liquid chromatography–tandem mass spectrometry using enzyme-assisted derivatisation. Biochem. Biophys. Res. Commun. 446 (2014), 745–750.
101. [101] Björkhem, I., Diczfalusy, U., Lövgren-Sandblom, A., Starck, L., Jonsson, M., Tallman, K., Schirmer, H., Ousager, L.B., Crick, P.J., Wang, Y., Griffiths, W.J., Guengerich, F.P., On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO. J. Lipid Res. 55 (2014), 1165–1172.
102. [102] Wassif, C.A., Yu, J., Cui, J., Porter, F.D., Javitt, N.B., 27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway. Steroids 68 (2003), 497–502.
103. [103] Honda, A., Salen, G., Shefer, S., Batta, A.K., Honda, M., Xu, G., Tint, G.S., Matsuzaki, Y., Shoda, J., Tanaka, N., Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver. J. Lipid Res. 40 (1999), 1520–1528.
104. [104] Sanchez-Guijo, A., Oji, V., Hartmann, M.F., Schuppe, H.C., Traupe, H., Wudy, S.A., High levels of oxysterol sulfates in serum of patients with steroid sulfatase deficiency. J. Lipid Res. 56 (2015), 403–412.
105. [105] Lütjohann, D., Schött, H.F., Lövgren-Sandblom, A., Geilenkeuser, W.J., Björkhem, I., Evaluation of the second worldwide non-cholesterol and oxysterol survey providing standard solutions. 4th ENOR Symposium, Translational Research on Oxysterols, 2014.
106. [106] Sjövall, J., Fifty years with bile acids and steroids in health and disease. Lipids 39 (2004), 703–722.
107. [107] Murphy, R.C., Steroids Tandem Mass Spectrometry of Lipids: Molecular analysis of complex lipids. 2014, Royal Society of Chemistry, Cambridge, 233–273.
108. [108] van de Merbel, N.C., Bronsema, K.J., van Hout, M.W., Nilsson, R., Sillén, H., A validated liquid chromatography-tandem mass spectrometry method for the quantitative determination of 4beta-hydroxycholesterol in human plasma. J. Pharm. Biomed. Anal. 55 (2011), 1089–1095.
109. [109] Ikegami, T., Hyogo, H., Honda, A., Miyazaki, T., Tokushige, K., Hashimoto, E., Inui, K., Matsuzaki, Y., Tazuma, S., Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease. J. Gastroenterol. 47 (2012), 1257–1266.
110. [110] Bodin, K., Bretillon, L., Aden, Y., Bertilsson, L., Broome, U., Einarsson, C., Diczfalusy, U., Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J. Biol. Chem. 276 (2001), 38685–38689.
111. [111] Axelson, M., Sjövall, J., Potential bile acid precursors in plasma-possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man. J. Steroid Biochem. 36 (1990), 631–640.